Cargando…
Cellular and Molecular Mechanisms of R/S-Roscovitine and CDKs Related Inhibition under Both Focal and Global Cerebral Ischemia: A Focus on Neurovascular Unit and Immune Cells
Ischemic stroke is the second leading cause of death worldwide. Following ischemic stroke, Neurovascular Unit (NVU) inflammation and peripheral leucocytes infiltration are major contributors to the extension of brain lesions. For a long time restricted to neurons, the 10 past years have shown the em...
Autores principales: | Le Roy, Lucas, Letondor, Anne, Le Roux, Cloé, Amara, Ahmed, Timsit, Serge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827530/ https://www.ncbi.nlm.nih.gov/pubmed/33429982 http://dx.doi.org/10.3390/cells10010104 |
Ejemplares similares
-
Principal component analysis, a useful tool to study cyclin-dependent kinase-inhibitor’s effect on cerebral ischaemia
por: Le Roy, Lucas, et al.
Publicado: (2020) -
Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma Cells
por: Vella, Serena, et al.
Publicado: (2016) -
For cdks, one is enough
por: Leslie, Mitch
Publicado: (2007) -
Delayed Treatment with Systemic (S)-Roscovitine Provides Neuroprotection and Inhibits In Vivo CDK5 Activity Increase in Animal Stroke Models
por: Menn, Bénédicte, et al.
Publicado: (2010) -
Cdks set the replication schedule
por: Leslie, Mitch
Publicado: (2010)